# L_2016197DE.01002801.xml

| 22.7.2016 | DE | Amtsblatt der Europäischen Union | L 197/28 |
| --- | --- | --- | --- |

22.7.2016

DE

Amtsblatt der Europäischen Union

L 197/28

---

Berichtigung der Verordnung (EU) Nr. 944/2013 der Kommission vom 2. Oktober 2013 zur Änderung der Verordnung (EG) Nr. 1272/2008 des Europäischen Parlaments und des Rates über die Einstufung, Kennzeichnung und Verpackung von Stoffen und Gemischen zwecks Anpassung an den technischen und wissenschaftlichen Fortschritt

(
  Amtsblatt der Europäischen Union L 261 vom 3. Oktober 2013
  )

Seite 9, Anhang II zur Änderung von Einträgen in Anhang VI Teil 3 Tabelle 3.1 der Verordnung (EG) Nr. 1272/2008 erhält folgende Fassung:

„ANHANG II

| Index-Nr. | Internationale chemische Bezeichnung | EG-Nr. | CAS-Nr. | Einstufung | Kennzeichnung | Spezifische Konzentrationsgrenzen
  M-Faktoren | Anmerkungen |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung | Kodierung der Gefahrenhinweise | Piktogramm, Kodierung der Signalworte | Kodierung der Gefahrenhinweise | Kodierung der ergänzenden Gefahrenmerkmale |
| 015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Acute Tox. 1 | H330 | Dgr | H330 | |
| Aquatic Acute 1 | H400 | | H400 | |
| 015-005-00-3 | magnesium phosphide;
  trimagnesium
  diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Acute Tox. 1 | H330 | Dgr | H330 |
| Aquatic Acute 1 | H400 | | H400 |
| 015-123-00-5 | fenamiphos (ISO);
  ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | H300 | GHS06 | H300 | | M = 100 | |
| Acute Tox. 2 | H310 | GHS09 | H310 | M = 100 |
| Acute Tox. 2 | H330 | Dgr | H330 | |
| Eye Irrit. 2 | H319 | | H319 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | | H413 | | | |
| 602-006-00-4 | chloroform;
  trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | H351 | GHS06 | H351 | | | |
| Repr. 2 | H361d | GHS08 | H361d |
| Acute Tox. 3 | H331 | Dgr | H331 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 | | H372 |
| Eye Irrit. 2 | H319 | | H319 |
| Skin Irrit. 2 | H315 | | H315 |
| 603-097-00-3 | 1,1′,1′′-nitrilotripropan-2-ol;
  triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 605-008-00-3 | acrolein;
  prop-2-enal;
  acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | EUH071 | Skin Corr. 1; H314: C ≥ 0,1 % | D |
| Acute Tox. 1 | H330 | GHS06 | H330 | |
| Acute Tox. 2 | H300 | GHS05 | H300 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Skin Corr. 1 | H314 | Dgr | H314 | |
| Aquatic Acute 1 | H400 | | | | M = 100 |
| Aquatic Chronic 1 | H410 | | H410 | | M = 1 |
| 607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Carc. 2 | H351 | GHS08 | H351 |
| Acute Tox. 4 | H332 | GHS07 | H332 |
| STOT SE 3 | H335 | Dgr | H335 |
| 607-613-00-8 | reaction mass of: | succinic acid |

Index-Nr.

Internationale chemische Bezeichnung

EG-Nr.

CAS-Nr.

Einstufung

Kennzeichnung

Spezifische Konzentrationsgrenzen

M-Faktoren

Anmerkungen

Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung

Kodierung der Gefahrenhinweise

Piktogramm, Kodierung der Signalworte

Kodierung der Gefahrenhinweise

Kodierung der ergänzenden Gefahrenmerkmale

015-004-00-8

aluminium phosphide

244-088-0

20859-73-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Dgr

H330

Aquatic Acute 1

H400

H400

015-005-00-3

magnesium phosphide;

trimagnesium

diphosphide

235-023-7

12057-74-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Dgr

H330

Aquatic Acute 1

H400

H400

015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-1

22224-92-6

Acute Tox. 2

H300

GHS06

H300

M = 100

Acute Tox. 2

H310

GHS09

H310

M = 100

Acute Tox. 2

H330

Dgr

H330

Eye Irrit. 2

H319

H319

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

Aquatic Chronic 4

H413

H413

602-006-00-4

chloroform;

trichloromethane

200-663-8

67-66-3

Carc. 2

H351

GHS06

H351

Repr. 2

H361d

GHS08

H361d

Acute Tox. 3

H331

Dgr

H331

Acute Tox. 4

H302

H302

STOT RE 1

H372

H372

Eye Irrit. 2

H319

H319

Skin Irrit. 2

H315

H315

603-097-00-3

1,1′,1′′-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4

122-20-3

Eye Irrit. 2

H319

GHS07

Wng

H319

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4

107-02-8

Flam. Liq. 2

H225

GHS02

H225

EUH071

Skin Corr. 1; H314: C ≥ 0,1 %

D

Acute Tox. 1

H330

GHS06

H330

Acute Tox. 2

H300

GHS05

H300

Acute Tox. 3

H311

GHS09

H311

Skin Corr. 1

H314

Dgr

H314

Aquatic Acute 1

H400

M = 100

Aquatic Chronic 1

H410

H410

M = 1

607-023-00-0

vinyl acetate

203-545-4

108-05-4

Flam. Liq. 2

H225

GHS02

H225

D

Carc. 2

H351

GHS08

H351

Acute Tox. 4

H332

GHS07

H332

STOT SE 3

H335

Dgr

H335

607-613-00-8

reaction mass of:

succinic acid

| | monopersuccinic acid |
| --- | --- |

monopersuccinic acid

| | dipersuccinic acid |
| --- | --- |

dipersuccinic acid

| | monomethyl ester of succinic acid |
| --- | --- |

monomethyl ester of succinic acid

| | monomethyl ester of persuccinic acid |
| --- | --- |

monomethyl ester of persuccinic acid

| | dimethyl succinate |
| --- | --- |

dimethyl succinate

| | glutaric acid |
| --- | --- |

glutaric acid

| | monoperglutaric acid |
| --- | --- |

monoperglutaric acid

| | diperglutaric acid |
| --- | --- |

diperglutaric acid

| | monomethyl ester of glutaric acid |
| --- | --- |

monomethyl ester of glutaric acid

| | monomethyl ester of perglutaric acid |
| --- | --- |

monomethyl ester of perglutaric acid

| | dimethyl glutarate |
| --- | --- |

dimethyl glutarate

| | adipic acid |
| --- | --- |

adipic acid

| | monoperadipic acid |
| --- | --- |

monoperadipic acid

| | diperadipic acid |
| --- | --- |

diperadipic acid

| | monomethyl ester of adipic acid |
| --- | --- |

monomethyl ester of adipic acid

| | monomethyl ester of peradipic acid |
| --- | --- |

monomethyl ester of peradipic acid

| | dimethyl adipate |
| --- | --- |

dimethyl adipate

| | hydrogen peroxide |
| --- | --- |

hydrogen peroxide

| | methanol |
| --- | --- |

methanol

| | water |
| --- | --- |

water

432-790-1

Acute Tox. 4*

H332

GHS07

H332

Acute Tox. 4*

H312

GHS05

H312

Acute Tox. 4*

H302

GHS08

H302

Skin Corr. 1B

H314

Dgr

H314

STOT SE 2

H371 (Augen)

H371 (Augen)

609-003-00-7

nitrobenzene

202-716-0

98-95-3

Carc. 2.

H351

GHS06

H351

Repr. 1B

H360F

GHS08

H360F

Acute Tox. 3

H301

Dgr

H301

Acute Tox. 3

H331

H331

Acute Tox. 3

H311

H311

STOT RE 1

H372 (Blut)

H372 (Blut)

Aquatic Chronic 3

H412

H412

612-120-00-6

aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline

277-704-1

74070-46-5

Carc. 2

H351

GHS08

H351

M = 100

M = 10

Skin Sens. 1A

H317

GHS07

H317

Aquatic Acute 1

H400

GHS09

Aquatic Chronic 1

H410

Wng

H410

613-175-00-9

epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2

133855-98-8

Carc. 2

H351

GHS08

H351

Repr. 1B

H360Df

GHS09

H360Df

Aquatic Chronic 2

H411

Dgr

H411

616-200-00-1

reaction mass of N,N′-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N′-ethane-1,2-diylbis(12-hydroxyoctadecan amide)

432-430-3

Aquatic Chronic 4

H413

H413

648-055-00-5

pitch, coal tar, high-temp.;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-2

65996-93-2

Carc. 1A

H350

GHS08

H350

M = 1000

M = 1000

Muta. 1B

H340

GHS09

H340

Repr. 1B

H360FD

Dgr

H360FD

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

649-330-00-2

naphtha (petroleum),

hydrodesulphurized

heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-4

64742-82-1

Carc. 1B

H350

GHS08

H350

P

Muta. 1B

H340

Dgr

H340

STOT RE 1

H372 (zentrales Nervensystem)

H372 (zentrales Nervensystem)

Asp. Tox. 1

H304

H304

649-345-00-4

stoddard solvent;

Low boiling point

naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-3

8052-41-3

Carc. 1B

H350

GHS08

H350

P“

Muta. 1B

H340

Dgr

H340

STOT RE 1

H372 (zentrales Nervensystem)

H372 (zentrales Nervensystem)

Asp. Tox. 1

H304

H304

649-405-00-X

solvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-7

64742-88-7

STOT RE 1

H372 (zentrales Nervensystem)

GHS08

H372 (zentrales Nervens ystem)

Asp. Tox. 1

H304

Dgr

H304

Seite 13, Anhang III zur Einfügung von Einträgen in Anhang VI Teil 3 Tabelle 3.1 der Verordnung (EG) Nr. 1272/2008 erhält folgende Fassung:

„ANHANG III

| Index-Nr. | Internationale chemische Bezeichnung | EG-Nr. | CAS-Nr. | Einstufung | Kennzeichnung | Spezifische Konzentrationsgrenzen
  M-Faktoren | Anmerkungen |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung | Kodierung der Gefahrenhinweise | Piktogramm, Kodierung der Signalworte | Kodierung der Gefahrenhinweise | Kodierung der ergänzenden Gefahrenmerkmale |
| 031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. 1B | H350 | GHS08 | H350 | | | |
| STOT RE 1 | H372 (Atemsystem und hämatopoetisches System) | Dgr | H372 (Atemsystem und hämatopoetisches System) |
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H336 | GHS08
  Dgr | H336 |
| 606-145-00-1 | sulcotrione (ISO);
  2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione | | 99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | | M = 1
  M = 10 | |
| STOT RE 2 | H373 (Nieren) | GHS07 | H373 (Nieren) |
| Skin Sens. 1A | H317 | HS09 | H317 |
| Aquatic Acute 1 | H400 | Wng | |
| Aquatic Chronic 1 | H410 | | H410 |
| 607-699-00-7 | bifenthrin (ISO);
  (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate | | 82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | | M = 10000
  M = 100000 | |
| Acute Tox. 3 | H331 | GHS08 | H331 |
| Acute Tox. 2 | H300 | GHS09 | H300 |
| STOT RE 1 | H372 (Nerven-system) | Dgr | H372 (Nerven-system) |
| Skin Sens. 1B | H317 | | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 607-700-00-0 | indoxacarb (ISO);
  methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] | | 173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | | M = 1
  M = 1 | |
| Acute Tox. 4 | H332 | GHS08 | H332 |
| STOT RE 1 | H372 (Blut, Nervensystem, Herz) | GHS09 | H372 (Blut, Nervensystem, Herz) |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
  methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] | 144171-61-9 [2] | | | | |
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | | |
| 607-703-00-7 | ammoniumpentadeca-fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D |
| Lact. | H362 | GHS05 | H362 |
| Acute Tox. 4 | H332 | Dgr | H332 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 (Leber) | | H372 (Leber) |
| Eye Dam.1 | H318 | | H318 |
| 607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D |
| Lact. | H362 | GHS05 | H362 |
| Acute Tox. 4 | H332 | Dgr | H332 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 (Leber) | | H372 (Leber) |
| Eye Dam. 1 | H318 | | H318 |
| 612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | | M = 10
  M = 10 | |
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS08 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) |
| Skin Irrit. 2 | H315 | GHS09 | H315 |
| Eye Dam. 1 | H318 | Dgr | H318 |
| Aquatic Acute 1 | H400 | | H410 |
| Aquatic Chronic 1 | H410 | | |
| 612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H335 | GHS08 | H335 |
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS09 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) |
| Skin Corr. 1B | H314 | Dgr | H314 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | | M = 10
  M = 10 | |
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS05 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) |
| Skin Irrit. 2 | H315 | GHS09 | H315 |
| Eye Dam. 1 | H318 | Dgr | H318 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H335 | GHS08 | H335 |
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS09 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) |
| Skin Corr. 1B | H314 | Dgr | H314 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS08 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) |
| Skin Corr. 1B | H314 | GHS09 | H314 |
| Aquatic Acute 1 | H400 | Dgr | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-206-00-4 | flufenoxuron (ISO);
  1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea | 417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | | M = 10000
  M = 10000 | |
| Aquatic Acute 1 | H400 | Wng | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. 2 | H351 | GHS05 | H351 | | M = 10
  M = 10 | |
| Acute Tox. 4 | H302 | GHS07 | H302 |
| STOT RE 1 | H372 (Atemwege) (Inhalation) | GHS08 | H372 (Atemwege)
  (Inhalation) |
| Eye Dam. 1 | H318 | GHS09 | H318 |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-208-00-5 | N-ethyl-2-pyrrolidone;
  1-ethylpyrrolidin-2-one | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 616-209-00-0 | amidosulfuron (ISO);
  3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea | 407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | H410 | | M = 100
  M = 100 | |
| Aquatic Chronic 1 | H410 | Wng | |
| 616-210-00-6 | tebufenpyrad (ISO);
  N-(4-tertbutylbenzyl)-
  4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-
  carboxamide | | 119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | | M = 10
  M = 10 | |
| Acute Tox. 4 | H332 | GHS08 | H332 |
| STOT RE 2 | H373 (Magen-Darm-Trakt) (oral) | GHS09 | H373 (Magen-Darm-Trakt) (oral) |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-211-00-1 | proquinazid (ISO);
  6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one | | 189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | | M = 1 | |
| Aquatic Acute 1 | H400 | GHS09 | | | M = 10“ |
| Aquatic Chronic 1 | H410 | Wng | H410 | | |

Index-Nr.

Internationale chemische Bezeichnung

EG-Nr.

CAS-Nr.

Einstufung

Kennzeichnung

Spezifische Konzentrationsgrenzen

M-Faktoren

Anmerkungen

Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung

Kodierung der Gefahrenhinweise

Piktogramm, Kodierung der Signalworte

Kodierung der Gefahrenhinweise

Kodierung der ergänzenden Gefahrenmerkmale

031-001-00-4

gallium arsenide

215-114-8

1303-00-0

Carc. 1B

H350

GHS08

H350

STOT RE 1

H372 (Atemsystem und hämatopoetisches System)

Dgr

H372 (Atemsystem und hämatopoetisches System)

050-025-00-6

trichloromethylstannane

213-608-8

993-16-8

Repr. 2

H361d

GHS08

Wng

H361d

050-026-00-1

2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-828-5

57583-34-3

Repr. 2

H361d

GHS08

Wng

H361d

050-027-00-7

2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

239-622-4

15571-58-1

Repr. 1B

H360D

GHS08

Dgr

H360D

601-087-00-3

2,4,4-trimethylpentene

246-690-9

25167-70-8

Flam. Liq. 2

H225

GHS02

H225

D

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H336

GHS08

Dgr

H336

606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

Repr. 2

H361d

GHS08

H361d

M = 1

M = 10

STOT RE 2

H373 (Nieren)

GHS07

H373 (Nieren)

Skin Sens. 1A

H317

HS09

H317

Aquatic Acute 1

H400

Wng

Aquatic Chronic 1

H410

H410

607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

Carc. 2

H351

GHS06

H351

M = 10000

M = 100000

Acute Tox. 3

H331

GHS08

H331

Acute Tox. 2

H300

GHS09

H300

STOT RE 1

H372 (Nerven-system)

Dgr

H372 (Nerven-system)

Skin Sens. 1B

H317

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1]

Acute Tox. 3

H301

GHS06

H301

M = 1

M = 1

Acute Tox. 4

H332

GHS08

H332

STOT RE 1

H372 (Blut, Nervensystem, Herz)

GHS09

H372 (Blut, Nervensystem, Herz)

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2]

607-702-00-1

dihexyl phthalate

201-559-5

84-75-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-703-00-7

ammoniumpentadeca-fluorooctanoate

223-320-4

3825-26-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Dgr

H332

Acute Tox. 4

H302

H302

STOT RE 1

H372 (Leber)

H372 (Leber)

Eye Dam.1

H318

H318

607-704-00-2

perfluorooctanoic acid

206-397-9

335-67-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Dgr

H332

Acute Tox. 4

H302

H302

STOT RE 1

H372 (Leber)

H372 (Leber)

Eye Dam. 1

H318

H318

612-282-00-8

octadecylamine

204-695-3

124-30-1

Asp. Tox. 1

H304

GHS05

H304

M = 10

M = 10

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS08

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Dgr

H318

Aquatic Acute 1

H400

H410

Aquatic Chronic 1

H410

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS09

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

Dgr

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-284-00-9

amines, hydrogenated tallow alkyl

262-976-6

61788-45-2

Asp Tox. 1

H304

GHS08

H304

M = 10

M = 10

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS05

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Dgr

H318

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-285-00-4

amines, coco alkyl

262-977-1

61788-46-3

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS09

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

Dgr

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-286-00-X

amines, tallow alkyl

263-125-1

61790-33-8

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS08

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

GHS09

H314

Aquatic Acute 1

H400

Dgr

Aquatic Chronic 1

H410

H410

616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3

101463-69-8

Lact.

H362

GHS09

H362

M = 10000

M = 10000

Aquatic Acute 1

H400

Wng

Aquatic Chronic 1

H410

H410

616-207-00-X

polyhexamethylene biguanide hydrochloride

27083-27-8 or 32289-58-0

Carc. 2

H351

GHS05

H351

M = 10

M = 10

Acute Tox. 4

H302

GHS07

H302

STOT RE 1

H372 (Atemwege) (Inhalation)

GHS08

H372 (Atemwege)

(Inhalation)

Eye Dam. 1

H318

GHS09

H318

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-6

2687-91-4

Repr. 1B

H360D

GHS08

Dgr

H360D

616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

Aquatic Acute 1

H400

GHS09

H410

M = 100

M = 100

Aquatic Chronic 1

H410

Wng

616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-

4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-

carboxamide

119168-77-3

Acute Tox. 3

H301

GHS06

H301

M = 10

M = 10

Acute Tox. 4

H332

GHS08

H332

STOT RE 2

H373 (Magen-Darm-Trakt) (oral)

GHS09

H373 (Magen-Darm-Trakt) (oral)

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

Carc. 2

H351

GHS08

H351

M = 1

Aquatic Acute 1

H400

GHS09

M = 10“

Aquatic Chronic 1

H410

Wng

H410

---